The UCLA Alport Syndrome Program is dedicated to providing the best healthcare, education and care to patients and families affected by Alport Syndrome. This program is committed to performing cutting-edge research and educating healthcare professionals about the latest advances in the field.

Alport Syndrome is a genetic condition characterized by kidney disease, hearing loss and eye abnormalities.

UCLA offers comprehensive care for Alport Syndrome through a team approach that includes collaboration among specialists in nephrology, pediatrics, genetics, ophthalmology, otorhinolaryngology, radiology, transplant, dialysis, psychiatry, social work and patient advocacy.

The UCLA Alport Syndrome Program is committed to ongoing research, including basic science, applied clinical science, outcomes, and evidence-based research, with a goal to develop new treatments and cures for Alport Syndrome.

Contact our research team for more information about Alport clinical trials.

Email: [email protected]

Learn how you can support the Alport Syndrome Program by visiting